Negative pressure on SP from release of Escrow aside...
Next milestone is probably granting of Ethics committee approval to start patient recruitment. In the January newsletter they said:
"We will shortly be submitting the protocol and support documentation to regulatory authorities and hospital ethics committees around the globe."
That cant be far away... and will be positive news.
Secondly, OncoCal is going to be the opening to injecting other solid tumours such as liver tumours - watch out Sirtex.
Delivery by per cutaneous injection is cheaper and easier than intra-arterial injection.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.16 |
Change
-0.070(5.69%) |
Mkt cap ! $16.49M | |||
| Open | High | Low | Value | Volume |
| $1.25 | $1.25 | $1.11 | $72.36K | 60.96K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 9286 | $1.16 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.18 | 412 | 1 |
View Market Depth
| Last trade - 16.10pm 27/06/2025 (20 minute delay) ? |
| OSL (ASX) Chart |